CG Oncology, Inc. Common stock (CGON) earnings · rev $4.0M
These earnings events as JSON? API free 100/dayCG Oncology, Inc. Common stock (CGON) is a biotechnology company listed on US.
This CGON earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported CGON revenue for 2025-12-31 was $4.0M. Net income was -$161.0M. Revenue was up 254.7% from 2024-12-31 to 2025-12-31. CGON currently screens at market cap $4.74B.
When the next CGON 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 254.7% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full CGON research stays on the stock page; the tape stays on the quote page.
CGON earnings FAQ
What are CGON's latest revenue and net income?
Latest cached CG Oncology, Inc. Common stock (CGON) revenue for Dec 31, 2025 was $4.0M. Net income was -$161.0M. Statements: https://lician.com/financials/cgon
What is CGON's latest diluted EPS?
Latest cached CG Oncology, Inc. Common stock (CGON) diluted EPS for Dec 31, 2025 was -$2.08.
What period does the latest CGON earnings print cover?
The latest cached CG Oncology, Inc. Common stock (CGON) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did CGON revenue change from the prior cached period?
Cached CG Oncology, Inc. Common stock (CGON) revenue was up 254.7% from $1.1M (Dec 31, 2024) to $4.0M (Dec 31, 2025). Statements: https://lician.com/financials/cgon
Where are CGON earnings listed?
Cached earnings facts for CG Oncology, Inc. Common stock (CGON) are listed at https://lician.com/earnings/cgon. Statements: https://lician.com/financials/cgon
Not investment advice.